Results 191 to 200 of about 16,498,742 (308)

Subtypes of Hepatitis B Surface Antigen in Turkey

open access: yesJapanese Journal of Infectious Diseases, 2005
Yalcinkaya, Kezban Tulay   +6 more
openaire   +2 more sources

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden   +13 more
wiley   +1 more source

A PEGylated nanobody against HBsAg exhibits pleiotropic antiviral efficacy in hepatitis B models. [PDF]

open access: yesJ Nanobiotechnology
Yang Q   +10 more
europepmc   +1 more source

[Distribution of hepatitis B surface antigen in the liver].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1985
SUGIMURA, Haruhiko   +3 more
openaire   +2 more sources

Innate Immune Activation Is a Strong Suppressor of CCL22 and Impedes Regulatory T Cell–Dendritic Cell Interaction

open access: yesImmunology, EarlyView.
During homeostasis, CCL22 is secreted by dendritic cells (DC), which mediate contacts between regulatory T cells (Treg) and DC to maintain immune balance. Activation of innate immunity via microbes or pattern recognition receptor (PRR) agonists induces the secretion of several soluble factors (e.g., type I and II interferons, IL‐10), which mediate ...
Ignazio Piseddu   +24 more
wiley   +1 more source

Progress in Protein Nanoparticle Vaccines for Human Viral Diseases. [PDF]

open access: yesACS Omega
He Y   +8 more
europepmc   +1 more source

Gaps in the Cascade of Care Contribute to Poor Liver Cancer Outcomes Among People Living With Hepatitis B: A Multicenter Observational Cohort Study

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa   +23 more
wiley   +1 more source

Rheumatic fever and hepatitis B surface antigen.

open access: yesThe Turkish journal of pediatrics, 1981
M Ertuğrul, Y Gungen
openaire   +2 more sources

Home - About - Disclaimer - Privacy